View ValuationShanghai Huide Science & TechnologyLtd 将来の成長Future 基準チェック /06現在、 Shanghai Huide Science & TechnologyLtdの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長30.0%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesNew Risk • May 06New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.1% Last year net profit margin: 4.9% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.7% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (3.1% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding).お知らせ • Apr 30Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 22, 2026Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 22, 2026, at 14:30 China Standard Time. Location: No. 180, Chunhua Road, Jinshanwei Town, Jinshan District, Shanghai Chinaお知らせ • Mar 30Shanghai Huide Science & Technology Co.,Ltd to Report Q1, 2026 Results on Apr 30, 2026Shanghai Huide Science & Technology Co.,Ltd announced that they will report Q1, 2026 results on Apr 30, 2026Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥22.20, the stock trades at a trailing P/E ratio of 29.4x. Average trailing P/E is 45x in the Chemicals industry in China. Total returns to shareholders of 14% over the past three years.New Risk • Mar 08New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 17% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.0% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (17% increase in shares outstanding).New Risk • Dec 31New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.2% average weekly change). Earnings have declined by 4.0% per year over the past 5 years. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥28.72, the stock trades at a trailing P/E ratio of 32.1x. Average trailing P/E is 43x in the Chemicals industry in China. Total returns to shareholders of 27% over the past three years.お知らせ • Dec 26Shanghai Huide Science & Technology Co.,Ltd to Report Fiscal Year 2025 Results on Apr 30, 2026Shanghai Huide Science & Technology Co.,Ltd announced that they will report fiscal year 2025 results on Apr 30, 2026Valuation Update With 7 Day Price Move • Nov 04Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to CN¥27.98, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 44x in the Chemicals industry in China. Total returns to shareholders of 44% over the past three years.Reported Earnings • Oct 29Third quarter 2025 earnings released: EPS: CN¥0.19 (vs CN¥0.24 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.19 (down from CN¥0.24 in 3Q 2024). Revenue: CN¥673.4m (down 9.4% from 3Q 2024). Net income: CN¥26.3m (down 19% from 3Q 2024). Profit margin: 3.9% (down from 4.4% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Oct 15Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥25.41, the stock trades at a trailing P/E ratio of 27x. Average trailing P/E is 42x in the Chemicals industry in China. Total returns to shareholders of 33% over the past three years.New Risk • Oct 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.0% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.5% average weekly change).お知らせ • Sep 30Shanghai Huide Science & Technology Co.,Ltd to Report Q3, 2025 Results on Oct 29, 2025Shanghai Huide Science & Technology Co.,Ltd announced that they will report Q3, 2025 results on Oct 29, 2025Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥27.45, the stock trades at a trailing P/E ratio of 29.5x. Average trailing P/E is 44x in the Chemicals industry in China. Total returns to shareholders of 9.6% over the past three years.お知らせ • Jun 30Shanghai Huide Science & Technology Co.,Ltd to Report First Half, 2025 Results on Aug 23, 2025Shanghai Huide Science & Technology Co.,Ltd announced that they will report first half, 2025 results on Aug 23, 2025Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Jian Jun Jia was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Declared Dividend • May 31Dividend increased to CN¥0.38Dividend of CN¥0.38 is 108% higher than last year. Ex-date: 5th June 2025 Payment date: 5th June 2025 Dividend yield will be 1.8%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (40% earnings payout ratio) but not covered by cash flows (160% cash payout ratio). The dividend has increased by an average of 5.7% per year over the past 6 years. However, payments have been volatile during that time. Earnings per share has remained steady over the last 5 years. Unless this trend deteriorates, it should provide adequate earnings cover for the dividend.New Risk • May 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.2% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (160% cash payout ratio). Share price has been volatile over the past 3 months (8.7% average weekly change).Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥19.46, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 38x in the Chemicals industry in China. Total loss to shareholders of 18% over the past three years.Reported Earnings • Apr 22Full year 2024 earnings released: EPS: CN¥0.90 (vs CN¥0.46 in FY 2023)Full year 2024 results: EPS: CN¥0.90 (up from CN¥0.46 in FY 2023). Revenue: CN¥2.67b (down 1.5% from FY 2023). Net income: CN¥124.6m (up 95% from FY 2023). Profit margin: 4.7% (up from 2.4% in FY 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has remained flat, which means it is well ahead of earnings.お知らせ • Apr 22Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 16, 2025Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 16, 2025, at 14:00 China Standard Time. Location: No. 180, Chunhua Road, Jinshanwei Town, Jinshan District, Shanghai ChinaValuation Update With 7 Day Price Move • Apr 08Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥15.30, the stock trades at a trailing P/E ratio of 24.7x. Average trailing P/E is 33x in the Chemicals industry in China. Total loss to shareholders of 34% over the past three years.分析記事 • Apr 01Shanghai Huide Science & TechnologyLtd (SHSE:603192) Will Be Hoping To Turn Its Returns On Capital AroundIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...お知らせ • Mar 28Shanghai Huide Science & Technology Co.,Ltd to Report Q1, 2025 Results on Apr 29, 2025Shanghai Huide Science & Technology Co.,Ltd announced that they will report Q1, 2025 results on Apr 29, 2025お知らせ • Dec 27Shanghai Huide Science & Technology Co.,Ltd to Report Fiscal Year 2024 Results on Apr 22, 2025Shanghai Huide Science & Technology Co.,Ltd announced that they will report fiscal year 2024 results on Apr 22, 2025Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.16 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.24 (up from CN¥0.16 in 3Q 2023). Revenue: CN¥743.3m (down 3.6% from 3Q 2023). Net income: CN¥32.6m (up 51% from 3Q 2023). Profit margin: 4.4% (up from 2.8% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.分析記事 • Oct 01Shanghai Huide Science & Technology Co.,Ltd (SHSE:603192) Investors Are Less Pessimistic Than ExpectedThere wouldn't be many who think Shanghai Huide Science & Technology Co.,Ltd's ( SHSE:603192 ) price-to-earnings (or...お知らせ • Sep 30Shanghai Huide Science & Technology Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Shanghai Huide Science & Technology Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥15.70, the stock trades at a trailing P/E ratio of 28.5x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 8.2% over the past three years.New Risk • Aug 28New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 24% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.Reported Earnings • Aug 20Second quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.20 (up from CN¥0.13 in 2Q 2023). Revenue: CN¥683.6m (up 1.9% from 2Q 2023). Net income: CN¥28.7m (up 57% from 2Q 2023). Profit margin: 4.2% (up from 2.7% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Jul 18Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥12.48, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 27x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years.分析記事 • Jul 17Some Investors May Be Worried About Shanghai Huide Science & TechnologyLtd's (SHSE:603192) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...お知らせ • Jun 28Shanghai Huide Science & Technology Co.,Ltd to Report First Half, 2024 Results on Aug 20, 2024Shanghai Huide Science & Technology Co.,Ltd announced that they will report first half, 2024 results on Aug 20, 2024New Risk • May 17New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.Buy Or Sell Opportunity • May 07Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 47% to CN¥16.21. The fair value is estimated to be CN¥13.48, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.7% over the last 3 years. Earnings per share has declined by 32%.分析記事 • May 06Shanghai Huide Science & TechnologyLtd (SHSE:603192) Is Posting Promising Earnings But The Good News Doesn’t Stop ThereShanghai Huide Science & Technology Co.,Ltd's ( SHSE:603192 ) recent earnings report didn't offer any surprises, with...Reported Earnings • Apr 30First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.09 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (up from CN¥0.09 in 1Q 2023). Revenue: CN¥670.5m (up 14% from 1Q 2023). Net income: CN¥14.7m (up 17% from 1Q 2023). Profit margin: 2.2% (in line with 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.お知らせ • Apr 21Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 13, 2024Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 13, 2024, at 13:00 China Standard Time.Reported Earnings • Apr 20Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥0.50 in FY 2022)Full year 2023 results: EPS: CN¥0.46. Revenue: CN¥2.71b (down 10% from FY 2022). Net income: CN¥63.9m (up 3.4% from FY 2022). Profit margin: 2.4% (up from 2.0% in FY 2022). The increase in margin was driven by lower expenses.Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to CN¥12.89, the stock trades at a trailing P/E ratio of 35.4x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years.お知らせ • Mar 29Shanghai Huide Science & Technology Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024Shanghai Huide Science & Technology Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 10% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (1.9% net profit margin).分析記事 • Mar 08There's Reason For Concern Over Shanghai Huide Science & Technology Co.,Ltd's (SHSE:603192) Massive 27% Price JumpThose holding Shanghai Huide Science & Technology Co.,Ltd ( SHSE:603192 ) shares would be relieved that the share price...Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 29%After last week's 29% share price decline to CN¥11.81, the stock trades at a trailing P/E ratio of 31.9x. Average trailing P/E is 24x in the Chemicals industry in China. Total loss to shareholders of 25% over the past three years.Valuation Update With 7 Day Price Move • Jan 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥18.00, the stock trades at a trailing P/E ratio of 48.6x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 10% over the past three years.お知らせ • Dec 29Shanghai Huide Science & Technology Co.,Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024Shanghai Huide Science & Technology Co.,Ltd announced that they will report fiscal year 2023 results on Apr 20, 2024Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.15 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.16 (up from CN¥0.15 in 3Q 2022). Revenue: CN¥770.8m (up 4.5% from 3Q 2022). Net income: CN¥21.6m (up 4.3% from 3Q 2022). Profit margin: 2.8% (in line with 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Reported Earnings • Aug 29Second quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.25 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.25 in 2Q 2022). Revenue: CN¥671.0m (down 17% from 2Q 2022). Net income: CN¥18.3m (down 16% from 2Q 2022). Profit margin: 2.7% (in line with 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.お知らせ • Jun 28Shanghai Huide Science & Technology Co.,Ltd to Report First Half, 2023 Results on Aug 29, 2023Shanghai Huide Science & Technology Co.,Ltd announced that they will report first half, 2023 results on Aug 29, 2023Reported Earnings • Apr 24Full year 2022 earnings released: EPS: CN¥0.50 (vs CN¥0.85 in FY 2021)Full year 2022 results: EPS: CN¥0.50 (down from CN¥0.85 in FY 2021). Revenue: CN¥3.02b (down 5.5% from FY 2021). Net income: CN¥61.8m (down 48% from FY 2021). Profit margin: 2.0% (down from 3.7% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.26 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.15 (down from CN¥0.26 in 3Q 2021). Revenue: CN¥737.4m (down 23% from 3Q 2021). Net income: CN¥20.7m (down 40% from 3Q 2021). Profit margin: 2.8% (down from 3.6% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 5% per year.Reported Earnings • Aug 20Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.25. Revenue: CN¥807.2m (up 5.2% from 2Q 2021). Net income: CN¥21.8m (down 29% from 2Q 2021). Profit margin: 2.7% (down from 4.0% in 2Q 2021). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • Aug 01Investor sentiment improved over the past weekAfter last week's 23% share price gain to CN¥28.00, the stock trades at a trailing P/E ratio of 34.2x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 42% over the past three years.Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥28.72, the stock trades at a trailing P/E ratio of 35x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 38% over the past three years.Valuation Update With 7 Day Price Move • May 23Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥31.77, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 25x in the Chemicals industry in China. Total returns to shareholders of 24% over the past three years.Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.24 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.20 (down from CN¥0.24 in 1Q 2021). Revenue: CN¥820.9m (up 52% from 1Q 2021). Net income: CN¥21.0m (down 16% from 1Q 2021). Profit margin: 2.6% (down from 4.7% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 6% per year.Reported Earnings • Apr 21Full year 2021 earnings released: EPS: CN¥1.10 (vs CN¥1.16 in FY 2020)Full year 2021 results: EPS: CN¥1.10 (down from CN¥1.16 in FY 2020). Revenue: CN¥3.19b (up 113% from FY 2020). Net income: CN¥117.8m (down 5.2% from FY 2020). Profit margin: 3.7% (down from 8.3% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.Valuation Update With 7 Day Price Move • Jan 25Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥40.76, the stock trades at a trailing P/E ratio of 30.1x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 46% over the past three years.Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥58.36, the stock trades at a trailing P/E ratio of 43.1x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 110% over the past three years.Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 23% share price gain to CN¥50.04, the stock trades at a trailing P/E ratio of 37x. Average trailing P/E is 35x in the Chemicals industry in China. Total returns to shareholders of 66% over the past three years.Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.27 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥961.3m (up 107% from 3Q 2020). Net income: CN¥34.7m (up 21% from 3Q 2020). Profit margin: 3.6% (down from 6.2% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 9% per year, which means it is performing significantly worse than earnings.Reported Earnings • Aug 20Second quarter 2021 earnings released: EPS CN¥0.28 (vs CN¥0.22 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥767.7m (up 187% from 2Q 2020). Net income: CN¥30.7m (up 28% from 2Q 2020). Profit margin: 4.0% (down from 9.0% in 2Q 2020). The decrease in margin was driven by higher expenses.Reported Earnings • Apr 21Full year 2020 earnings released: EPS CN¥1.16 (vs CN¥1.24 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥1.50b (up 4.0% from FY 2019). Net income: CN¥124.2m (down 6.0% from FY 2019). Profit margin: 8.3% (down from 9.2% in FY 2019). The decrease in margin was driven by higher expenses.Is New 90 Day High Low • Jan 13New 90-day low: CN¥20.50The company is down 23% from its price of CN¥26.47 on 15 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Dec 28New 90-day low: CN¥22.76The company is down 10.0% from its price of CN¥25.26 on 29 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.Is New 90 Day High Low • Dec 10New 90-day low: CN¥24.97The company is down 3.0% from its price of CN¥25.63 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥100.7m, down 20% from the prior year. Total revenue was CN¥1.32b over the last 12 months, down 5.1% from the prior year.Is New 90 Day High Low • Sep 28New 90-day low: CN¥24.98The company is down 4.0% from its price of CN¥26.00 on 30 June 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.お知らせ • Jul 09Shanghai Huide Science & Technology Co.,Ltd to Report First Half, 2020 Results on Aug 21, 2020Shanghai Huide Science & Technology Co.,Ltd announced that they will report first half, 2020 results on Aug 21, 2020 このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Shanghai Huide Science & TechnologyLtd は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測SHSE:603192 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20262,48977257295N/A12/31/20252,47281204329N/A9/30/20252,464125202314N/A6/30/20252,534131106232N/A3/31/20252,61112933161N/A12/31/20242,671125-2228N/A9/30/20242,7828750100N/A6/30/20242,80976100142N/A3/31/20242,79666128167N/A12/31/20232,71264193239N/A9/30/20232,6795199201N/A6/30/20232,6465139148N/A3/31/20232,7825457162N/A12/31/20223,01762-4157N/A9/30/20223,28891-3223N/A6/30/20223,5121041782N/A3/31/20223,47311362147N/A12/31/20213,191118129257N/A9/30/20212,82314480235N/A6/30/20212,326138104273N/A3/31/20211,826132-2169N/A12/31/20201,4981244162N/A9/30/20201,322101-56111N/A6/30/20201,264108-9478N/A3/31/20201,344124-38130N/A12/31/20191,440132N/A89N/A9/30/20191,392126N/A58N/A6/30/20191,439122N/A78N/A3/31/20191,529118N/A93N/A12/31/20181,593115N/A90N/A9/30/20181,638116N/A172N/A3/31/20181,491100N/AN/AN/A12/31/20171,426110N/A117N/A12/31/20161,17498N/A194N/A12/31/20151,13153N/A131N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 603192の予測収益成長が 貯蓄率 ( 2.4% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 603192の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 603192の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 603192の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 603192の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 603192の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/14 22:05終値2026/06/12 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Shanghai Huide Science & Technology Co.,Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • May 06New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.1% Last year net profit margin: 4.9% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.7% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (3.1% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding).
お知らせ • Apr 30Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 22, 2026Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 22, 2026, at 14:30 China Standard Time. Location: No. 180, Chunhua Road, Jinshanwei Town, Jinshan District, Shanghai China
お知らせ • Mar 30Shanghai Huide Science & Technology Co.,Ltd to Report Q1, 2026 Results on Apr 30, 2026Shanghai Huide Science & Technology Co.,Ltd announced that they will report Q1, 2026 results on Apr 30, 2026
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥22.20, the stock trades at a trailing P/E ratio of 29.4x. Average trailing P/E is 45x in the Chemicals industry in China. Total returns to shareholders of 14% over the past three years.
New Risk • Mar 08New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 17% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.0% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (17% increase in shares outstanding).
New Risk • Dec 31New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.2% average weekly change). Earnings have declined by 4.0% per year over the past 5 years. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥28.72, the stock trades at a trailing P/E ratio of 32.1x. Average trailing P/E is 43x in the Chemicals industry in China. Total returns to shareholders of 27% over the past three years.
お知らせ • Dec 26Shanghai Huide Science & Technology Co.,Ltd to Report Fiscal Year 2025 Results on Apr 30, 2026Shanghai Huide Science & Technology Co.,Ltd announced that they will report fiscal year 2025 results on Apr 30, 2026
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to CN¥27.98, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 44x in the Chemicals industry in China. Total returns to shareholders of 44% over the past three years.
Reported Earnings • Oct 29Third quarter 2025 earnings released: EPS: CN¥0.19 (vs CN¥0.24 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.19 (down from CN¥0.24 in 3Q 2024). Revenue: CN¥673.4m (down 9.4% from 3Q 2024). Net income: CN¥26.3m (down 19% from 3Q 2024). Profit margin: 3.9% (down from 4.4% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥25.41, the stock trades at a trailing P/E ratio of 27x. Average trailing P/E is 42x in the Chemicals industry in China. Total returns to shareholders of 33% over the past three years.
New Risk • Oct 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.0% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.5% average weekly change).
お知らせ • Sep 30Shanghai Huide Science & Technology Co.,Ltd to Report Q3, 2025 Results on Oct 29, 2025Shanghai Huide Science & Technology Co.,Ltd announced that they will report Q3, 2025 results on Oct 29, 2025
Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥27.45, the stock trades at a trailing P/E ratio of 29.5x. Average trailing P/E is 44x in the Chemicals industry in China. Total returns to shareholders of 9.6% over the past three years.
お知らせ • Jun 30Shanghai Huide Science & Technology Co.,Ltd to Report First Half, 2025 Results on Aug 23, 2025Shanghai Huide Science & Technology Co.,Ltd announced that they will report first half, 2025 results on Aug 23, 2025
Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Jian Jun Jia was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Declared Dividend • May 31Dividend increased to CN¥0.38Dividend of CN¥0.38 is 108% higher than last year. Ex-date: 5th June 2025 Payment date: 5th June 2025 Dividend yield will be 1.8%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (40% earnings payout ratio) but not covered by cash flows (160% cash payout ratio). The dividend has increased by an average of 5.7% per year over the past 6 years. However, payments have been volatile during that time. Earnings per share has remained steady over the last 5 years. Unless this trend deteriorates, it should provide adequate earnings cover for the dividend.
New Risk • May 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.2% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (160% cash payout ratio). Share price has been volatile over the past 3 months (8.7% average weekly change).
Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥19.46, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 38x in the Chemicals industry in China. Total loss to shareholders of 18% over the past three years.
Reported Earnings • Apr 22Full year 2024 earnings released: EPS: CN¥0.90 (vs CN¥0.46 in FY 2023)Full year 2024 results: EPS: CN¥0.90 (up from CN¥0.46 in FY 2023). Revenue: CN¥2.67b (down 1.5% from FY 2023). Net income: CN¥124.6m (up 95% from FY 2023). Profit margin: 4.7% (up from 2.4% in FY 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
お知らせ • Apr 22Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 16, 2025Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 16, 2025, at 14:00 China Standard Time. Location: No. 180, Chunhua Road, Jinshanwei Town, Jinshan District, Shanghai China
Valuation Update With 7 Day Price Move • Apr 08Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥15.30, the stock trades at a trailing P/E ratio of 24.7x. Average trailing P/E is 33x in the Chemicals industry in China. Total loss to shareholders of 34% over the past three years.
分析記事 • Apr 01Shanghai Huide Science & TechnologyLtd (SHSE:603192) Will Be Hoping To Turn Its Returns On Capital AroundIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...
お知らせ • Mar 28Shanghai Huide Science & Technology Co.,Ltd to Report Q1, 2025 Results on Apr 29, 2025Shanghai Huide Science & Technology Co.,Ltd announced that they will report Q1, 2025 results on Apr 29, 2025
お知らせ • Dec 27Shanghai Huide Science & Technology Co.,Ltd to Report Fiscal Year 2024 Results on Apr 22, 2025Shanghai Huide Science & Technology Co.,Ltd announced that they will report fiscal year 2024 results on Apr 22, 2025
Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.16 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.24 (up from CN¥0.16 in 3Q 2023). Revenue: CN¥743.3m (down 3.6% from 3Q 2023). Net income: CN¥32.6m (up 51% from 3Q 2023). Profit margin: 4.4% (up from 2.8% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
分析記事 • Oct 01Shanghai Huide Science & Technology Co.,Ltd (SHSE:603192) Investors Are Less Pessimistic Than ExpectedThere wouldn't be many who think Shanghai Huide Science & Technology Co.,Ltd's ( SHSE:603192 ) price-to-earnings (or...
お知らせ • Sep 30Shanghai Huide Science & Technology Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Shanghai Huide Science & Technology Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥15.70, the stock trades at a trailing P/E ratio of 28.5x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 8.2% over the past three years.
New Risk • Aug 28New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 24% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
Reported Earnings • Aug 20Second quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.20 (up from CN¥0.13 in 2Q 2023). Revenue: CN¥683.6m (up 1.9% from 2Q 2023). Net income: CN¥28.7m (up 57% from 2Q 2023). Profit margin: 4.2% (up from 2.7% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Jul 18Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥12.48, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 27x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years.
分析記事 • Jul 17Some Investors May Be Worried About Shanghai Huide Science & TechnologyLtd's (SHSE:603192) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...
お知らせ • Jun 28Shanghai Huide Science & Technology Co.,Ltd to Report First Half, 2024 Results on Aug 20, 2024Shanghai Huide Science & Technology Co.,Ltd announced that they will report first half, 2024 results on Aug 20, 2024
New Risk • May 17New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
Buy Or Sell Opportunity • May 07Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 47% to CN¥16.21. The fair value is estimated to be CN¥13.48, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.7% over the last 3 years. Earnings per share has declined by 32%.
分析記事 • May 06Shanghai Huide Science & TechnologyLtd (SHSE:603192) Is Posting Promising Earnings But The Good News Doesn’t Stop ThereShanghai Huide Science & Technology Co.,Ltd's ( SHSE:603192 ) recent earnings report didn't offer any surprises, with...
Reported Earnings • Apr 30First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.09 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (up from CN¥0.09 in 1Q 2023). Revenue: CN¥670.5m (up 14% from 1Q 2023). Net income: CN¥14.7m (up 17% from 1Q 2023). Profit margin: 2.2% (in line with 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 21Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 13, 2024Shanghai Huide Science & Technology Co.,Ltd, Annual General Meeting, May 13, 2024, at 13:00 China Standard Time.
Reported Earnings • Apr 20Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥0.50 in FY 2022)Full year 2023 results: EPS: CN¥0.46. Revenue: CN¥2.71b (down 10% from FY 2022). Net income: CN¥63.9m (up 3.4% from FY 2022). Profit margin: 2.4% (up from 2.0% in FY 2022). The increase in margin was driven by lower expenses.
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to CN¥12.89, the stock trades at a trailing P/E ratio of 35.4x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years.
お知らせ • Mar 29Shanghai Huide Science & Technology Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024Shanghai Huide Science & Technology Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024
New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 10% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (1.9% net profit margin).
分析記事 • Mar 08There's Reason For Concern Over Shanghai Huide Science & Technology Co.,Ltd's (SHSE:603192) Massive 27% Price JumpThose holding Shanghai Huide Science & Technology Co.,Ltd ( SHSE:603192 ) shares would be relieved that the share price...
Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 29%After last week's 29% share price decline to CN¥11.81, the stock trades at a trailing P/E ratio of 31.9x. Average trailing P/E is 24x in the Chemicals industry in China. Total loss to shareholders of 25% over the past three years.
Valuation Update With 7 Day Price Move • Jan 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥18.00, the stock trades at a trailing P/E ratio of 48.6x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 10% over the past three years.
お知らせ • Dec 29Shanghai Huide Science & Technology Co.,Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024Shanghai Huide Science & Technology Co.,Ltd announced that they will report fiscal year 2023 results on Apr 20, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.15 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.16 (up from CN¥0.15 in 3Q 2022). Revenue: CN¥770.8m (up 4.5% from 3Q 2022). Net income: CN¥21.6m (up 4.3% from 3Q 2022). Profit margin: 2.8% (in line with 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Reported Earnings • Aug 29Second quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.25 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.25 in 2Q 2022). Revenue: CN¥671.0m (down 17% from 2Q 2022). Net income: CN¥18.3m (down 16% from 2Q 2022). Profit margin: 2.7% (in line with 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 28Shanghai Huide Science & Technology Co.,Ltd to Report First Half, 2023 Results on Aug 29, 2023Shanghai Huide Science & Technology Co.,Ltd announced that they will report first half, 2023 results on Aug 29, 2023
Reported Earnings • Apr 24Full year 2022 earnings released: EPS: CN¥0.50 (vs CN¥0.85 in FY 2021)Full year 2022 results: EPS: CN¥0.50 (down from CN¥0.85 in FY 2021). Revenue: CN¥3.02b (down 5.5% from FY 2021). Net income: CN¥61.8m (down 48% from FY 2021). Profit margin: 2.0% (down from 3.7% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.26 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.15 (down from CN¥0.26 in 3Q 2021). Revenue: CN¥737.4m (down 23% from 3Q 2021). Net income: CN¥20.7m (down 40% from 3Q 2021). Profit margin: 2.8% (down from 3.6% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 5% per year.
Reported Earnings • Aug 20Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.25. Revenue: CN¥807.2m (up 5.2% from 2Q 2021). Net income: CN¥21.8m (down 29% from 2Q 2021). Profit margin: 2.7% (down from 4.0% in 2Q 2021). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • Aug 01Investor sentiment improved over the past weekAfter last week's 23% share price gain to CN¥28.00, the stock trades at a trailing P/E ratio of 34.2x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 42% over the past three years.
Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥28.72, the stock trades at a trailing P/E ratio of 35x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 38% over the past three years.
Valuation Update With 7 Day Price Move • May 23Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥31.77, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 25x in the Chemicals industry in China. Total returns to shareholders of 24% over the past three years.
Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.24 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.20 (down from CN¥0.24 in 1Q 2021). Revenue: CN¥820.9m (up 52% from 1Q 2021). Net income: CN¥21.0m (down 16% from 1Q 2021). Profit margin: 2.6% (down from 4.7% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 6% per year.
Reported Earnings • Apr 21Full year 2021 earnings released: EPS: CN¥1.10 (vs CN¥1.16 in FY 2020)Full year 2021 results: EPS: CN¥1.10 (down from CN¥1.16 in FY 2020). Revenue: CN¥3.19b (up 113% from FY 2020). Net income: CN¥117.8m (down 5.2% from FY 2020). Profit margin: 3.7% (down from 8.3% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.
Valuation Update With 7 Day Price Move • Jan 25Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥40.76, the stock trades at a trailing P/E ratio of 30.1x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 46% over the past three years.
Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥58.36, the stock trades at a trailing P/E ratio of 43.1x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 110% over the past three years.
Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 23% share price gain to CN¥50.04, the stock trades at a trailing P/E ratio of 37x. Average trailing P/E is 35x in the Chemicals industry in China. Total returns to shareholders of 66% over the past three years.
Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.27 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥961.3m (up 107% from 3Q 2020). Net income: CN¥34.7m (up 21% from 3Q 2020). Profit margin: 3.6% (down from 6.2% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 9% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Aug 20Second quarter 2021 earnings released: EPS CN¥0.28 (vs CN¥0.22 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥767.7m (up 187% from 2Q 2020). Net income: CN¥30.7m (up 28% from 2Q 2020). Profit margin: 4.0% (down from 9.0% in 2Q 2020). The decrease in margin was driven by higher expenses.
Reported Earnings • Apr 21Full year 2020 earnings released: EPS CN¥1.16 (vs CN¥1.24 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥1.50b (up 4.0% from FY 2019). Net income: CN¥124.2m (down 6.0% from FY 2019). Profit margin: 8.3% (down from 9.2% in FY 2019). The decrease in margin was driven by higher expenses.
Is New 90 Day High Low • Jan 13New 90-day low: CN¥20.50The company is down 23% from its price of CN¥26.47 on 15 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Dec 28New 90-day low: CN¥22.76The company is down 10.0% from its price of CN¥25.26 on 29 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.
Is New 90 Day High Low • Dec 10New 90-day low: CN¥24.97The company is down 3.0% from its price of CN¥25.63 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.
Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥100.7m, down 20% from the prior year. Total revenue was CN¥1.32b over the last 12 months, down 5.1% from the prior year.
Is New 90 Day High Low • Sep 28New 90-day low: CN¥24.98The company is down 4.0% from its price of CN¥26.00 on 30 June 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.
お知らせ • Jul 09Shanghai Huide Science & Technology Co.,Ltd to Report First Half, 2020 Results on Aug 21, 2020Shanghai Huide Science & Technology Co.,Ltd announced that they will report first half, 2020 results on Aug 21, 2020